In individuals suffering from diabetic kidney disease (DKD), the engagement of G-protein coupled receptors (GPRs) by short-chain fatty acids (SCFAs) elicits an enhancement in the secretion of glucagon-like peptide-1 (GLP-1), which consequently enhances glucose tolerance and insulin sensitivity. Here, INS is linked to diabetic kidney disease.